Dermatology News: 2007.29

• 2007.29(4) Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases
  A phase 3 trial was conducted to evaluate the efficacy of a prophylactic quadrivalent vaccine in preventing anogenital diseases associated with human papillomavirus (HPV) types 6, 11, 16, and 18...   |   Read more ...



• 2007.29(3) Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions
  Human papillomavirus types 16 (HPV-16) and 18 (HPV-18) cause approximately 70% of cervical cancers worldwide. A phase 3 trial was conducted to evaluate a quadrivalent vaccine against HPV types 6, 11, 16, and 18...   |   Read more ...



• 2007.29(2) Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers.
  In the new WHO-European Organisation for Research and Treatment of Cancer (WHO-EORTC) classification for cutaneous lymphomas three major groups of primary cutaneous B-cell lymphoma (CBCL) are distinguished...   |   Read more ...



• 2007.29(1) The impact of aggressive debridement used as an adjunct therapy with terbinafine on perceptions of patients undergoing treatment for toenail onychomycosis
  To determine whether adding aggressive debridement to oral terbinafine for treating toenail onychomycosis impacts patient-reported outcomes (PROs)...   |   Read more ...

    Current Year Archive:   Dermatology News 2007   |   Main Archive:   Dermatology News  

The Derm News service provided by the Editorial Consultants of Skin Therapy Letter^© and its founding editor Dr. Stuart Maddin.